The Risk and Outcomes of Pneumonia in Patients on Inhaled Corticosteroids

Publication date: Available online 5 May 2015 Source:Pulmonary Pharmacology & Therapeutics Author(s): Oriol Sibila , Natalia Soto-Gomez , Marcos I. Restrepo Corticosteroids are frequently prescribed anti-inflammatory medications. Inhaled corticosteroids (ICS) are indicated for Chronic Obstructive Pulmonary Disease (COPD) and asthma. ICSs are associated with a decrease in exacerbations and improved quality of life in COPD, however multiple studies have linked the chronic use of ICSs with an increased risk of developing pneumonia, though the effect on mortality is unclear. We review the association of ICS with the risk of pneumonia and the implications on clinical outcomes.
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research